Markets › India › NSE › VIMTALABS

Vimta Labs Ltd

NSE:VIMTALABSHealthcare

₹504.70−3.40%At closeAt close · Mon 19 Oct · ≈ AED 19.50 · Market cap $245.95M · Next earnings Sat 14 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	70.7%	33.1%	76.6%	76.0%	38.5%	38.9%	—	—
Operating margin	17.3%	20.0%	22.1%	19.5%	25.5%	24.4%	24.4%	+0.0 pts
Net margin	10.3%	15.0%	15.3%	12.9%	19.6%	19.0%	19.0%	+0.0 pts
EBITDA margin	25.6%	29.1%	30.7%	28.3%	36.7%	35.1%	—	—
Return on equity	11.0%	17.7%	17.1%	12.8%	17.8%	17.0%	17.0%	+0.0 pts
Return on assets	7.8%	13.5%	13.3%	10.3%	14.4%	13.8%	13.8%	+0.0 pts
Return on capital employed	16.4%	21.3%	22.8%	17.9%	21.8%	20.0%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	11.1%	6.3%	4.1%	4.8%	1.8%	0.6%	—	—
Interest coverage	16.6×	43.9×	50.9×	40.6×	46.2×	85.1×	—	—
Current ratio	2.1×	2.6×	2.9×	2.9×	2.9×	3.4×	3.4×	+0.0%
Quick ratio	1.8×	2.2×	2.5×	2.5×	2.5×	3.0×	—	—
Cash ratio	0.1×	0.2×	0.5×	0.2×	0.2×	1.0×	1.0×	+0.0%
Asset turnover	0.8×	0.9×	0.9×	0.8×	0.7×	0.7×	—	—
Inventory turnover	4.2×	10.6×	3.3×	3.1×	8.4×	8.3×	—	—
Receivables turnover	2.8×	3.6×	3.9×	3.6×	3.2×	3.9×	—	—
Dividend payout	0.0%	10.7%	9.2%	10.8%	6.6%	5.7%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.